Comparison of loss of response between anti-tumor necrosis factor alone and combined use with immunomodulators in patients with inflammatory bowel disease-Reference-Cited by-同舟云学术

Comparison of loss of response between anti-tumor necrosis factor alone and combined use with immunomodulators in patients with inflammatory bowel disease

Published:2021-03-01 Issue:Suppl 1 Volume:36 Page:S9-S17
ISSN:1226-3303
Container-title:The Korean Journal of Internal Medicine
language:en
Short-container-title:Korean J Intern Med

Author:

Hong Seung Wook,Park Jaewoo,Yoon Hyuk,Yang Hye Ran,Shin Cheol Min,Park Young Soo,Kim Nayoung,Lee Dong Ho,Kim Joo Sung

Publisher

Korean Association of Internal Medicine

Link

http://kjim.org/upload/kjim-2019-279.pdf

Reference15 articles.

1. Current and emerging therapeutic targets for IBD

2. Loss of Response to Anti-TNFs: Definition, Epidemiology, and Management

3. Review article: loss of response to anti-TNF treatments in Crohn’s disease

4. Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

5. Combination Therapy With Infliximab and Azathioprine Is Superior to Monotherapy With Either Agent in Ulcerative Colitis

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Old and New Biologics and Small Molecules in Inflammatory Bowel Disease: Anti Integrins;The Korean Journal of Gastroenterology;2024-08-25

2. Effect of Overweight and Obesity on the Response to Anti-TNF Therapy and Disease Course in Children With IBD;Inflammatory Bowel Diseases;2024-07-31

3. Dopamine β-hydroxylase shapes intestinal inflammation through modulating T cell activation;Cellular Immunology;2024-07

4. The impact of 5-aminosalicylates on the efficacy of mesenchymal stem cell therapy in a murine model of ulcerative colitis;International Immunopharmacology;2024-06

5. Effectiveness of strategies to suppress antibodies to infliximab in pediatric inflammatory bowel disease;Journal of Pediatric Gastroenterology and Nutrition;2023-12-05